There is a growing body of evidence indicating that mTOR inhibitors are the preferred treatment for diabetic nephropathy [18], which is primarily associated with reduced proteinuria and albuminuria [18, 26]. The gene discussed is MTOR; the disease is diabetic kidney disease.